SPY313.78-3.27 -1.03%
DIA259.04-3.96 -1.51%
IXIC10,343.89-89.76 -0.86%

Stemline Therapeutics Sees Prelim. Q4 Net Revenues For ELZONRIS $11.8M, Sees $43.2M In FY19

Benzinga · -